BioHarvest - CEO, Ilan Sobel
CEO, Ilan Sobel
Source: BioHarvest
  • Common shares of BioHarvest Sciences (BHSC) are now trading on the OTCQB Venture Market under the ticker symbol CNVCF
  • Trading on the OTCQB will provide BioHarvest with added visibility to U.S. investors
  • BioHarvest Sciences will continue to trade on the Canadian Securities Exchange (CSE) as BHSC
  • BioHarvest Sciences has developed a bio-cell growth platform capable of growing the ingredients in fruit and plants without the need to grow the plant itself
  • BioHarvest Sciences Inc. (BHSC) is up 2 per cent on the day, trading at C$0.25 per share at 2:15 pm ET

Common shares of BioHarvest Sciences (BHSC) are now trading on the OTCQB Venture Market under the ticker symbol CNVCF. CEO Ilan Sobel commented on the listing.

“Admission to the OTCQB market is an important step to increase US investor access to BioHarvest Sciences, and it provides US investors an additional level of transparency as we expand both our investor base and our customer base in North America. We will continue to work on expanding our global visibility to investors to match the commercial entry of our products into new markets.”

The OTCQB Venture Market is for early-stage and developing U.S. and international companies. To be eligible, companies must be current in their financial reporting and undergo an annual verification and management certification process.

BioHarvest Sciences will continue to trade on the Canadian Securities Exchange (CSE) as BHSC.

BioHarvest Sciences Inc. (BHSC) is a fast-growing Biotech firm that has developed a patented bio-cell growth platform technology capable of growing the active and beneficial ingredients in fruit and plants, at industrial scale, without the need to grow the plant itself.

BioHarvest Sciences Inc. (BHSC) is up 2 per cent on the day, trading at C$0.25 per share at 2:15 pm ET.

More From The Market Online